← Mechanisms of action
Q72874
SINGLE PROTEINHuman immunodeficiency virus 1
Preferred name: Human immunodeficiency virus type 1 protease ChEMBL ↗
Linked proteins
Drugs acting on this target (12)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| amprenavir (agenerase) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| atazanavir (reyataz) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| brecanavir | Inhibitor | experimental | Small molecule | HIV-1 protease inhibitor |
| darunavir (prezista) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| fosamprenavir (lexiva) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| indinavir (crixivan) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| lopinavir (Kaletra) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| nelfinavir (viracept) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| ritonavir (Norvir) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| saquinavir (invirase) | Inhibitor | approved | Small molecule | Q72874 inhibitor |
| telinavir | Inhibitor | experimental | Small molecule | HIV-1 protease inhibitor |
| tipranavir (aptivus) | Inhibitor | approved | Small molecule | Q72874 inhibitor |